This inventor holds 2 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Cancer Research Technology Limited, The Francis Crick Institute Limited, University College London. Active years: 2021-2023.
Company Filing History:
2 out of 268 
1 out of 11 
1 out of 119 
Years Active: 2021-2023
Title: Rachel Rosenthal: Innovator in Cancer Research
Introduction
Rachel Rosenthal is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly in the area of immune checkpoint interventions and HLA allele analysis in tumors. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
Rachel's latest patents include "Analysis of HLA alleles in tumours and the uses thereof." This invention relates to a method for determining whether an HLA allele is lost in a tumor in a subject. The method involves determining the specific copy number of the HLA allele in the tumor. Additionally, it encompasses a method for treating cancer by targeting a neoantigen presented by an HLA molecule that has not been lost in the tumor. Another notable patent is "Immune checkpoint intervention in cancer," which focuses on identifying subjects with cancer suitable for immune checkpoint treatment and predicting their prognosis.
Career Highlights
Throughout her career, Rachel has worked with esteemed organizations such as Cancer Research Technology Limited and The Francis Crick Institute Limited. Her innovative approaches and research have garnered attention in the scientific community, contributing to the understanding and treatment of cancer.
Collaborations
Rachel has collaborated with notable colleagues, including Nicholas McGranahan and Charles Swanton. These partnerships have further enhanced her research and the impact of her inventions in the field of oncology.
Conclusion
In summary, Rachel Rosenthal is a trailblazer in cancer research, with her patents and collaborations significantly advancing the understanding and treatment of cancer. Her work continues to inspire future innovations in the medical field.